UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 176 filers reported holding UNIQURE NV in Q2 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,497,000 | +4.0% | 46,766 | 0.0% | 0.54% | +6.2% |
| Q2 2021 | $1,440,000 | +2.3% | 46,766 | +12.0% | 0.51% | -15.0% |
| Q1 2021 | $1,407,000 | +11.2% | 41,766 | +19.3% | 0.60% | +5.2% |
| Q4 2020 | $1,265,000 | +10.8% | 35,000 | +12.9% | 0.57% | -14.6% |
| Q3 2020 | $1,142,000 | +24.5% | 31,000 | +52.3% | 0.67% | +33.7% |
| Q2 2020 | $917,000 | +35.9% | 20,358 | +43.2% | 0.50% | +17.6% |
| Q1 2020 | $675,000 | +92.3% | 14,220 | +190.2% | 0.43% | +200.0% |
| Q4 2019 | $351,000 | – | 4,900 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |